S-8 1 d488014ds8.htm S-8 S-8

As filed with the Securities and Exchange Commission on April 5, 2023.

Registration No. 333-        

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM S-8

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

 

UpHealth, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   83-3838045

(State or other jurisdiction of

incorporation or organization)

  

(I.R.S. Employer

Identification No.)

14000 S. Military Trail, Suite 203

Delray Beach, FL 33484

(Address, including Zip Code, of Principal Executive Offices)

2021 Equity Incentive Plan

(Full title of the plan)

Samuel J. Meckey

Chief Executive Officer

UpHealth, Inc.

14000 S. Military Trail, Suite 203

Delray Beach, Florida 33484

Tel: (888) 424-3646

(Name, address, and telephone number, including area code, of agent for service)

Copy to:

Jeffrey C. Selman, Esq.

DLA Piper LLP (US)

555 Mission Street, Suite 2400

San Francisco, CA 94105

(415) 615-6095

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   ☐    Accelerated filer   ☐
Non-accelerated filer   ☒    Smaller reporting company   ☒
     Emerging growth company   ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.  ☐

 

 

 

EXPLANATORY NOTE

This Registration Statement has been filed by UpHealth, Inc. (the “Registrant”) to register 754,976 additional shares of common stock, par value $0.0001 per share (“Common Stock”) of the Registrant, to be offered pursuant to the 2021 Equity Incentive Plan (the “Plan”).

Initial shares of the Plan were registered pursuant to that Registration Statement on Form S-8 (File No. 333-258735), filed with the Securities and Exchange Commission (the “Commission”) on August 12, 2021 (the “2021 Registration Statement”). Additional shares offered pursuant to the Plan were registered pursuant to that Registration Statement on Form S-8 (File No. 333-266024), filed with the Commission on July 6, 2022 (the “2022 Registration Statement”). Pursuant to General Instruction E to Form S-8 regarding registration of additional securities, the entire contents of the 2021 Registration Statement and the 2022 Registration Statement are incorporated herein by reference.

PART II

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3. Incorporation of Documents by Reference.

The following documents previously filed by the Registrant with the Commission under the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), are incorporated by reference into this Registration Statement:

 

  •  

The Registrant’s Annual Report on Form 10-K for the year ended December 31, 2022 filed with the Commission on March 31, 2023;

 

  •  

The Registrant’s Current Reports on Form 8-K filed with the Commission on January  3, 2023, January  13, 2023, February  27, 2023, March  9, 2023 and March 13, 2023; and

 

  •  

The description of the Registrant’s Common Stock contained in the Company’s Registration Statement on Form 8-A (File No. 001-38924), filed with the Commission on May 28, 2019 pursuant to the Exchange Act, including any amendment or report filed for the purpose of updating such description.

All documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be a part hereof from the date of filing of such documents.

Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

Item 8. Exhibits.

The following exhibits are filed as a part of or incorporated by reference into this Registration Statement:

 

Exhibit

No.

   

Exhibit Description

   

Filed

Herewith

   

Incorporated

by Reference

Herein from

Form or

Schedule

   

Filing Date

   

Commission
File / Reg.
Number

  4.1    Second Amended and Restated Certificate of Incorporation of UpHealth, Inc. as amended by the Certificate of Amendment effective December 8, 2022.       10-K    03/31/2023    001-38924
  4.2    Second Amended and Restated Bylaws of UpHealth, Inc., effective August 22, 2022.       8-K    08/24/2022    001-38924
  4.3    Specimen Common Stock Certificate of UpHealth, Inc.       10-K    03/31/2023    001-38924
  4.4    2021 Equity Incentive Plan.       8-K    06/15/2021    001-38924
  5.1    Opinion of DLA Piper LLP (US).    X         
23.1    Consent of BPM LLP, independent registered public accounting firm.    X         

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Minneapolis, Minnesota, on this 5th day of April, 2023.

 

UPHEALTH, INC.
By:  

/s/ Samuel J. Meckey

Name:   Samuel J. Meckey
Title:   Chief Executive Officer

POWER OF ATTORNEY

Each person whose signature appears below constitutes and appoints Samuel J. Meckey and Martin S. A. Beck and each or any one of them, his true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments to this Registration Statement on Form S-8, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the United States Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his substitutes or substitute, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement on Form S-8 has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.

 

Name    Title    Date

/s/ Samuel J. Meckey

    Chief Executive Officer, Director    April 5, 2023
Samuel J. Meckey    (Principal Executive Officer)   

/s/ Martin S. A. Beck

    Chief Financial Officer    April 5, 2023
Martin S. A. Beck    (Principal Financial and Accounting Officer)   

/s/ Dr. Avi S. Katz

    Chairman of the Board of Directors    April 5, 2023
Dr. Avi S. Katz      

/s/ Dr. Raluca Dinu

    Director    April 5, 2023
Dr. Raluca Dinu      

/s/ Agnès Rey-Giraud

    Director    April 5, 2023
Agnès Rey-Giraud      

/s/ Nathan Locke

    Director    April 5, 2023
Nathan Locke      

/s/ Mark Guinan

    Director    April 5, 2023
Mark Guinan      

/s/ Luis Machuca

    Director    April 5, 2023
Luis Machuca      

/s/ Dr. Mariya Pylypiv

    Director    April 5, 2023
Dr. Mariya Pylypiv      

/s/ Dr. Chirinjeev Kathuria

    Director    April 5, 2023
Dr. Chirinjeev Kathuria